Search
News & Events
Generous new funding to fast-track rare disease diagnosis and unlock new treatmentsResearch that screens novel genetic variants identified in disease will be fast-tracked by a funding boost, offering new hope of an early diagnosis for families of children with a rare or undiagnosed genetic disease.
News & Events
New national role for The Kids’ Executive DirectorThe Australian Government has appointed the National Health and Medical Research Council (NHMRC) Council for 2024 to 2027.
News & Events
Pioneering new treatments for leukaemia in children with Down syndromeA team of world-leading scientists has secured $5 million in funding from the Leukaemia and Lymphoma Society to advance the fight against leukaemia in children with Down syndrome.
News & Events
ORIGINS celebrates it’s 10,000th baby, reaching key recruitment milestoneAustralia’s biggest longitudinal study following the health and wellbeing of children from their conception through to childhood, has welcomed its 10,000th and final participant.
MECP2 duplication syndrome is a rare disorder neurodevelopmental disorder that, unlike Rett syndrome, mostly affects boys.
Our research covers a broad range of areas from the influence of mutation type on health outcomes to factors impacting on the lives of familes.
Research
Spotting sporotrichosis skin infection: The first Australian paediatric case seriesThese data highlight the importance of recognising Sporotrichosis in children outside an outbreak setting
Research
Children's neighbourhood physical environment and early development: an individual child level linked data studyThe neighbourhood physical environment has a weak but significant association with early childhood development
Research
Stillbirth risk prediction using machine learning for a large cohort of births from Western Australia, 1980–2015Almost half of stillbirths could be potentially identified antenatally based on a combination of factors
Research
Lessons learned in genetic research with Indigenous Australian participantsWe reflect on the lessons learned from a recent genome‐wide association study of rheumatic heart disease with Aboriginal Australian participants